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Abstract 
System A activity is a highly regulated mechanism for the active transport of zwitterionic amino acids into mammalian cells. 
Monoclonal antibodies generated against a previously unidentified rat liver plasma membrane-associated protein were shown to 
immunoprecipitate solubilized System A transport activity. The immunoreactive protein was later determined by immunoblotting and 
peptide microsequencing to be rat liver a-fodrin (non-erythroid spectrin). Antibody against ankyrin, a protein that often serves as a bridge 
between integral membrane proteins and fodrin, also immunoprecipitated System A transport activity. Fractionation of solubilized plasma 
membrane proteins on sucrose gradients revealed that the System A transporter co-migrated as a complex with fodrin and ankyrin, even in 
the presence of detergent and urea. In contrast, the System N amino acid transporter does not co-migrate with ankyrin and fodrin, nor 
does the anti-fodrin antibody immunoprecipitate System N activity. The present data are the first to demonstrate an association between 
an organic solute transporter and the membranocytoskeletal proteins ankyrin and fodrin. 
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1. Introduction 
Transport of neutral amino acids across the mammalian 
plasma membrane is mediated by several independent 
activities with distinct but overlapping substrate specificity 
[ 1,2]. System A, a Na +-dependent transporter that mediates 
the uptake of small neutral amino acids, has been detected 
in every nucleated cell or tissue type tested, and regulation 
is extensive [2-4]. A number of studies uggest that induc- 
tion of System A is the result of increased synthesis of a 
plasma membrane glycoprotein, either the transporter itself 
or an associated protein [5,6]. In the hepatocyte, newly 
synthesized System A transport activity is delivered first to 
the basolateral membrane, and then transferred by transcy- 
tosis to the canalicular domain [7]. 
Previous observations suggest hat there are important 
interactions between the cytoskeleton and amino acid 
transporters. We have recently shown by immunohisto- 
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chemistry that the cationic amino acid transporter CAT1 
(System y+ activity) exists within the fibroblast plasma 
membrane in discrete islands or clusters that appear to 
occur randomly over the entire cell surface [8]. In contrast, 
antibody against he GLUT1 glucose transporter demon- 
strated that it is uniformly distributed over the entire cell 
surface. Treatment with nocodazole to disrupt the micro- 
tubules resulted in dispersion of the CAT1 transporter over 
the entire cell surface that generated a staining pattern 
similar to GLUT1. Interestingly, the CATl-containing 
clusters reformed within 3 h after removal of the inhibitor 
and incubation of the cells in fresh medium. These changes 
in CAT1 clustering were paralleled by the appropriate 
changes in microtubule organization [8]. With regard to 
System A, in most cell types, disruption of the cyto- 
skeleton only slightly affects basal transport activity, but 
blocks hormone or adaptive induction by 40-80% [9-11]. 
Furthermore, Karl et al. [12] reported that use of chaotropic 
agents to strip cytoskeletal proteins from isolated placental 
plasma membrane vesicles resulted in the loss of System A 
transport activity. 
Studies investigating membrane-cytoskeleton interac- 
tions have demonstrated that ankyrin and fodrin (the latter 
sometimes referred to as 'non-erythroid spectrin') are im- 
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portant links between integral plasma membrane proteins 
and the cytoskeleton [13,14]. Ankyrin-fodrin complexes 
exhibit high-affinity binding sites for membrane proteins 
and may be involved in the maintenance of cell polarity 
for polarized epithelial cells [15-18]. Several ion transport 
proteins are complexed with ankyrin-fodrin including Na ÷ 
channel [19], Na ÷-Ca 2 ÷ exchanger [20], H ÷ K+-ATPase 
[21], and Na ÷ K+-ATPase [17,18,22,23]. It is proposed that 
selective localization of the Na +K ÷-ATPase to the basolat- 
eral membrane of polarized MDCK cells may be related to 
its interaction with the ankyrin-fodrin complex which is 
specifically associated with this membrane domain in con- 
fluent cells [17]. In support of this hypothesis, in retinal 
pigment epithelial cells where the localization of the 
Na+K÷-ATPase is 'reversed' such that the activity resides 
on the apical surface, the presence of ankyrin and fodrin is 
also predominantly apical in their distribution [18]. In the 
present study, we show that monoclonal antibodies against 
either a-fodrin or ankyrin co-precipitate the System A 
transporter and that, during sucrose density fractionation, 
the transport activity migrates in a complex with ankyrin 
and fodrin. 
2. Materials and methods 
2.1. Solubilization of System A activity 
Rat liver plasma membrane vesicles were isolated fol- 
lowing the protocol described by Prpic et al. [24]. System 
A transport activity and associated cytoskeletal compo- 
nents were solubilized by incubating the membranes in a 
buffer containing 2.5% cholate and 4 M urea [25]. After 
centrifugation for 1 h at 100000 X g, the proteins in the 
supernatant were precipitated with a final concentration of 
20% polyethylene glycol 8000 (PEG) by the addition of 2 
volumes of 30% PEG and incubation on ice for 15 min. 
The mixture was centrifuged at 100000 X g for 30 min, 
and the resulting pellet was washed three times in KMB 
buffer (200 mM KC1, 1 mM MgC12, and 10 mM Hepes, 
pH 7.5). The precipitated proteins were resuspended at a 
concentration of 1 mg protein/ml in STAB buffer (20% 
glycerol, 2 mM EDTA, 0.05% Triton X-100, 0.25% 
asolectin and 10 mM Tris, pH 7.4), as described previously 
[26]. After sonication for 10 s, the solution was centrifuged 
at 15 000 X g for 2 min to remove particulate matter and 
the proteins remaining in the supernatant were subjected to 
selective precipitation using 3% PEG. The final protein 
fraction is enriched for System A activity by 70-fold over 
that in plasma membrane vesicles (Table 1) and approx. 
2000-fold over that measured in total cell homogenates 
[25,27]. This System A-enriched protein fraction was used 
as antigen to immunize mice for the generation of mono- 
clonal antibodies. Protein content was determined by a 
modification of the Lowry procedure as previously de- 
scribed [25]. 
2.2. Preparation of monoclonal antibodies 
Monoclonal antibodies were prepared by the Hy- 
bridoma Core Facility of the Interdisciplinary Center for 
Biotechnology at the University of Florida using a modi- 
fied method of Kohler and Milstein [28]. Details of the 
preparation and screening of these hybridoma supernatants 
have been described [26]. 
2.3. lmmunodepletion f System A transport activity 
To test for precipitation of transporter activity by anti- 
body, an immunodepletion assay was performed as de- 
scribed previously [26]. Briefly, a 1-ml aliquot of the 
appropriate secondary antibody, covalently linked to 
agarose beads (Sigma Chemical Co., St. Louis, MO), was 
incubated for 1 h with hybridoma supernatant or 5 /xg of 
primary antibody IgG at 4°C and then centrifuged for 1 
min at 50 g, after which the supernatant was discarded. 
After incubation of the agarose-bound primary antibody 
for 1 h at 4°C with an aliquot of the solubilized membrane 
protein fraction enriched for System A and its associated 
proteins, the beads were pelleted at 50 g for 1 min and 
discarded. The supernatant was saved, dithiothreitol was 
added to a final concentration of 2 mM, and then the 
proteins were reconstituted into proteoliposomes. Negative 
controls included incubations employing agarose beads 
lacking a bound antibody or a bound antibody that was 
shown previously to produce no immunodepletion f Sys- 
tem A. System A transport activity was measured as the 
Na+-dependent uptake of 200 /zM [3H]2-aminoisobutyric 
acid (AIB) as described by Fafournoux et al. [25]. 
Table 1 
Enrichment of System A activity solubilized from rat liver plasma 
membrane 
Protein fraction A1B transport Fold- 
enrichment 
Plasma membrane v sicles 228 + 4 1 
SOLUB protein fraction 3185 + 132 14 
STAB protein fraction 16291 + 1474 72 
Rat liver plasma membrane v sicles were isolated from glucagon-treated 
animals. System A activity in vesicles or proteoliposomes was measured 
for one min at 37°C as the Na+-dependent up ake of 200 /~M [3H]AIB. 
The membrane vesicle transport activity was solubilized with 2.5% 
cholate/4 M urea, and then precipitated with 30% PEG. A portion of the 
pellet (SOLUB) was reconstituted to measure enrichment (SOLUB), and 
the remainder was resuspended in STAB buffer, sonicated for 10 s, 
centrifuged toremove non-solubilized material, and subjected toa selec- 
tive precipitation procedure using 3% PEG to obtain the maximum 
enrichment of System A activity [25]. The resulting pellet (STAB) was 
the material used to immunize mice for the production of antibody as 
indicated in Section 2. The transport velocities are expressed as pmol- 
rag- Iprotein, min- i and are the averages + S.D. of assays in quadrupli- 
cate. Similar esults were obtained in each of many independent experi- 
ments. 
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2.4. Fractionation of protein complexes on sucrose gradi- 
ents 
Rat liver plasma membrane proteins were solubilized 
for 30 min at 4°C in 1 ml of gradient buffer (10 mM 
Tris-HC1, pH 7.5, 145 mM KC1, 2 mM EGTA, 2 mM 
EDTA, 2 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl 
fluoride, 2 /xg/ml each of aprotinin, leupeptin, pepstatin, 
N-tosyl-L-phenylalanine chloromethyl ketone, and N~-p -
tosyl-L-lysine chloromethyl ketone) and 2.5% cholate or 
2.5% cbolate plus 2 M urea (see figure legends). Follow- 
ing centrifugation for 5 min at 48 000 X g, approx. 2 mg of 
protein (in 1 ml) was layered onto a 4.2 ml linear 5-20% 
(w/w) sucrose gradient prepared in gradient buffer. The 
gradient was centrifuged at 300 000 X g for 5 h at 4°C in a 
Beckman SW50.1 rotor and 18 fractions containing ap- 
prox. 0.25 ml each were collected. A portion of each 
fraction was used to measure the total protein content, 
determine the refractive index, and separate proteins for 
immunoblot analysis. Proteins in the remainder of each 
fraction were precipitated with a final concentration of 
20% PEG, and then System A activity was reconstituted 
into proteoliposomes and transport activity assayed as 
described above. 
selective protein precipitation with 3% PEG. The latter 
procedure causes precipitation of only 10% of the total 
protein, but nearly all of the System A transport activity 
[25]. Subsequent reconstitution i to proteoliposomes re- 
sulted in an enrichment of System A activity of more than 
70-fold over the value in plasma membrane vesicles (Table 
1). Analysis of this membrane protein fraction by 1D- 
PAGE revealed about 8-10 primary polypeptides and a 
number of minor proteins. After we discovered that a- 
fodrin is a component in this final fraction, we analyzed 
several of the intermediate steps along this purification 
scheme to establish that there was immunoblotting parallel 
enrichment between a-fodrin and the System A transport 
activity (data not shown). Immunization of mice for the 
production of monoclonal antibodies was performed using 
this partially purified transporter f action as antigen, as 
described previously [26]. The resulting hybridoma super- 
natants were screened for the ability to immunodeplete the 
System A activity prior to reconstitution and, as described 
below, a number of them were capable of precipitating 
System A activity. 
3.2. Fodrin is the antigen corresponding to the System 
A-precipitating monoclonal antibodies 
2.5. lmmunoblot analysis 
Protein samples were dissolved in sample dilution buffer 
and subjected to one-dimensional polyacrylamide g l elec- 
trophoresis and immunoblot analysis as described previ- 
ously [26]. Binding of primary antibody was detected by 
incubating the blots for 1 h in blocking buffer containing 
secondary antibody conjugated to horseradish peroxidase. 
Secondary antibody bound was assayed by use of an 
enhanced chemiluminescence kit according to the manu- 
facturer's instructions (Amersham Corp., Arlington 
Heights, IL). 
3. Results 
3.1. Partial purification of hepatic System A transporter 
actiuity 
System A activity present in rat liver plasma membrane 
proteins is not readily solubilized by detergents alone [25]. 
However, as first reported by McCormick et al. [29] for the 
Ehrlich cell, greater than 80% of the activity is released 
when 4 M urea is included uring the solubilization proce- 
dure [25]. Enhanced solubilization in the presence of urea 
has been described for fodrin as well [15]. Following 
solubilization of System A activity in 2.5% cholate/4 M 
urea and then precipitation by the addition of 30% PEG, 
extraction of a subset of proteins was achieved by resus- 
pension of the pellet in STAB buffer, sonication and 
centrifugation to remove non-soluble particulates, and then 
The System A-enriched membrane protein fraction used 
as antigen for the preparation of the monoclonal antibodies 
was subjected to immunoblotting after separation of the 
proteins by two-dimensional polyacrylamide gel elec- 
trophoresis [30]. After subcloning positive hybridomas by 
serial dilution, a large number of monoclonal antibodies 
recognized a polypeptide of approx. 240 kDa (data not 
shown). To positively identify the immunoreactive protein, 
after separation by 2D-PAGE the polypeptide was sub- 
jected to cyanogen bromide cleavage and subsequent mi- 
crosequencing by the Protein Core Facility of the Interdis- 
ciplinary Center for Biotechnology at the University of 
Florida. Three distinct peptide sequences were obtained 
and used to search the SWISS-PROT database for homolo- 
gous sequences using the IntelliGenetics Inc. software 
PC-GENE (Mountain View, CA). The only significant 
similarities that were identified resulted from a comparison 
of the peptide sequences to previously reported human and 
chicken c~-fodrin sequences. The 240 kDa polypeptide 
detected by our monoclonal antibodies is similar to the 
native size of a-fodrin [31,32]. As shown in Fig. 1, the 
first 25 residue peptide sequence from the rat was identical 
to residues 278-302 of both human [33,34] and chicken 
[35] a-fodrin. The second rat peptide, also 25 residues in 
length, differed from the human sequence (residues 380- 
404) by only one amino acid (Fig. 1) and was identical to 
the chicken sequence [35]. The third peptide, 31 residues 
in length, was analogous to residues 653-683 of either the 
chicken or human c~-fodrin sequence and contained one 
conservative substitution (isoleucine to valine) and one 
unknown residue. These data represent an overall amino 
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acid identity of 98% between the rat, chicken, and human 
sequences, consistent with published reports demonstrating 
a high degree of conservation of fodrin across species 
[34,36,37]. The published portions of rat kidney [38] and 
rat brain [36] a-fodrin sequences begin at residues 1292 
and 1776 of the chicken sequence [35] and therefore, do 
not contain our peptide sequences. 
3.3. Immunoprecipitation of System A transport activity by 
anti-fodrin antibody 
Following subcloning of positive hybridoma cell lines, 
a number of the o~-fodrin monoclonal antibodies, including 
2A12-1/1BI and several independent subclones of hy- 
bridoma 4H10-3 (1G1 and 4C9 are shown as examples), 
all produced about 30-35% immunodepletion f System A 
transport activity (Table 2). Experiments using serial dilu- 
tions of hybridoma supematants, previously concentrated 
5- to 10-fold in a protein microdialysis apparatus (Bio- 
Molecular Dynamics, Beaverton, OR), demonstrated that 
immunoprecipitation f transport activity was dependent 
on antibody concentration and inhibition of up to 79% 
could be achieved (e.g., 2736 ___ 191 and 564 _+ 49 pmol • 
mg-I protein • min-1 for control and anti-fodrin treatment, 
respectively). The oz-fodrin antibodies that immunode- 
pleted System A activity did not immunoprecipitate solubi- 
lized hepatic System N transport activity when tested 
under the same conditions (Table 2, see also Ref. [26]. 
System N is a Na+-dependent amino acid carrier with a 
markedly different substrate specificity than System A, but 
it is also present in the membrane protein fraction used for 
the immunodepletion assays and antibody production. We 
have previously reported that two monoclonal antibodies 
(1E7-3/4E3 and 3E1-2/4H1) that recognize a polypeptide 
of approximately 100 kDa and that are effective in immun- 
odepleting solubilized System N activity, do not immuno- 
precipitate System A activity [26]. 
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Fig. 1. Comparison of peptide sequences from the rat liver 2A12-1/ IBI  
antigen with human a-fodrin. The immunoreactive polypeptide was 
separated by 2D-PAGE, subjected to cyanogen bromide cleavage, and 
microsequenced as outlined in the text. The resulting peptide sequences 
were compared to the protein database SWISS-PROT for possible homol- 
ogous sequences. The most significant sequence matches were against 
chicken brain and human lung ot-fodrin. Of the 80 identified (1 unknown) 
residues contained within the three rat peptides, all but two were identical 
to the published human and chicken o~-fodrin sequences, as discussed in 
the text. 
Table 2 
Selective immunodepletion f System A activity by a-fodrin monoclonal 
antibodies 
Antibody/systems Transport Percent 
(pmol. mg-  i protein, min- ~ ) inhibition 
System A activity 
Control 2655 + 330 - 
2A12-1/IB1 1794_+ 252 32 * 
4H10-3/ IGI  1720+276 35 * 
4H10-3/4C9 1936_+ 170 27 " 
System N activity 
Control 2529 _+ 53 - 
2AI2-1/1B1 2482_+90 2 
Solubilized membrane proteins enriched for System A activity were 
subjected to immunodepletion prior to reconstitution as described in the 
text. System A and System N activities in the resulting proteoliposomes 
were measured as the Na+-dependent uptake of 200 ~M [3H]AIB or 50 
/xM [3H]glutamine, respectively, at 37°C for one min and are reported as 
the averages+S.D, for assay in quadruplicate. Immunodepletion was 
tested using antibody-containing culture medium from the hybridomas 
listed. Non-inhibitory monoclonal antibodies were used to obtain the 
negative 'control' velocities. A hybridoma medium was considered to be 
a negative control if it contained an antibody against a protein in the 
fraction, but did not produce inhibition of transport when compared to 
conditioned medium obtained from myeloma cell cultures. Two indepen- 
dent experiments are shown as representative from a large number of 
reproducible tests for immunodepletion of both Systems A and N. 
Statistical differences were determined by the Student's t-test and the * 
indicates a P-value of < 0.025. 
3.4. Immunoprecipitation of System A transport activity by 
anti-ankyrin antibody 
Fodrin binding to plasma membrane proteins is often 
bridged by an ankyrin molecule in between the two 
[13,16,22]. To determine if ankyrin was also associated 
with the hepatic System A transporter, anti-ankyrin anti- 
body, kindly provided by Dr. W. James Nelson (Stanford 
University) or obtained commercially (Zymed Laborato- 
ries, San Francisco), were used to test for immunoprecip- 
itation of enriched System A activity by the immunodeple- 
tion assay described above. As demonstrated for the fodrin 
monoclonal antibodies, the ankyrin antibody also caused a 
reproducible immunodepletion f System A activity. The 
reconstituted velocities were 2736 _+ 191 pmol • 
mg -1protein. min-l in the presence of a non-immune 
IgG and 1100 _+ 103 pmol • mg -l protein, min- I (P  < 
0.005) in the presence of anti-ankyrin IgG. We have not 
optimized this inhibition with regard to concentration of
antibody required for maximal immunoprecipitation f 
transporter, but tests with three different antibody concen- 
trations indicated that the inhibition was dependent on the 
concentration of the anti-ankyrin IgG. These results, sug- 
gesting that both ankyrin and fodrin are associated with the 
System A transporter, are supported by the co-migration of 
these three proteins on sucrose gradients as described 
below. 
M.E. Handlogten et al. / Biochimica et Biophysica Acta 1282 (1996) 107-114 111 
3.5. Co-migration of ankyrin, fodrin, and System A on 
sucrose gradients 
Nelson and Hammerton [23] have solubilized plasma 
membrane protein complexes and subjected them to frac- 
tionation on linear sucrose gradients to document he 
specific interaction between fodrin and the Na+K +- 
ATPase. A similar approach also was used by that research 
group to identify fodrin/E-cadherin complexes [16]. We 
have taken advantage of this same procedure to determine 
if the hepatic System A amino acid transport activity 
co-migrates with a-fodrin and ankyrin. The data in Fig. 2 
illustrate that the System A transport activity migrates at a 
higher density than the System N transporter p otein when 
solubilized membrane proteins are fractionated on a 5-20% 
sucrose gradient. When each of the collected fractions 
were tested for the presence of c~-fodrin and ankyrin by 
immunoblot analysis, those fractions exhibiting the highest 
System A transport activity, also contained the greatest 
amount of the two membranocytoskeletal proteins (Fig. 2). 
In contrast, the System N transporter migrated in fractions 
that contained a relatively small amount of ankyrin and no 
a-fodrin. 
As outlined in Section 2, the membrane protein fraction 
from which System A transport activity and fodrin were 
co-enriched was originally solubilized with 2.5% cholate 
containing 4 M urea. To further demonstrate that the 
association of ankyrin, a-fodrin, and the System A trans- 
port activity was reasonably strong, membrane proteins 
were solubilized in 2.5% cholate/2 M urea and then 
subjected to sucrose gradient fractionation i the presence 
of 1 M urea. The addition of urea to the fractionation 
buffer caused a shift in the migration of transport activity 
on the sucrose gradient, the peak transport occurring in 
fractions 4-5 instead of fractions 7-8 (compare Figs. 2 and 
3). However, when each of the gradient fractions were 
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tested by immunoblotting for the presence of ankyrin and 
a-fodrin, the location of these proteins also shifted such 
that there continued to be co-migration with System A 
activity. It is unlikely that migration of the three proteins 
would be shifted identically if they were migrating as 
individual proteins. Therefore, the data argue against ran- 
dom chance as an explanation of the co-migration of the 
three proteins in the absence of urea. These results docu- 
ment that the transporter-ankyrin-fodrin complex survives 
in the presence of 1 M urea. 
4.  D iscuss ion  
The data presented here demonstrate that monoclonal 
antibodies against rat liver ot-fodrin cause co-precipitation 
of System A transport activity. Along with ankyrin [13], 
fodrin is thought o play a role similar to that of red blood 
cell spectrin in maintaining membrane-cytoskeletal interac- 
tions [32]. Current models propose that ankyrin binds 
directly to integral plasma membrane proteins and fodrin 
serves as a bridge between the bound ankyrin and the 
cytoskeleton [22]. Our results show that anti-ankyrin anti- 
bodies also immunoprecipitate System A transport activity. 
Fodrin is associated with the plasma membrane as an 
'insoluble complex' as defined by insolubility in an extrac- 
tion buffer containing 150 mM salt and 0.5% Triton X-100 
[15,39]. Interestingly, attempts to solubilize System A 
transport activity in the presence of detergents alone, such 
as Triton X-100, have also proven unsuccessful [25]. For 
example, 1% cholate alone released only 14% of the total 
transport activity with the remainder still associated with 
the insoluble membrane pellet; Triton X-100, CHAPS, 
octyl glucoside, and Lubrol (C12E9) gave similar results. 
However, including 4 M urea with any of the detergents 
increased the solubilization of the transport activity to 80% 
or more [25]. Effective extraction by urea is also character- 
istic of fodrin release from detergent extracted plasma 
membrane remnants [15]. Co-enrichment of fodrin 
throughout he partial purification of System A transport 
activity provides further support that either the complex 
survives solubilization in the presence of 4 M urea or, less 
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likely, that reassociation occurs after removal of the urea 
by PEG precipitation. 
As shown previously for both the Na+K+-ATPase and 
E-cadherin [16,23], the association of the System A trans- 
port activity with ankyrin and a-fodrin was sufficiently 
stable to permit separation of the complex on sucrose 
gradients. That the solubilized complex survived gradient 
fractionation i the presence of 1 M urea underscores the 
strength of interaction between these proteins. Further- 
more, the observation that the System N transporter mi- 
grates independently of fodrin or ankyrin, and is not 
immunoprecipitated by anti-fodrin antibodies, demon- 
strates the specificity of the interaction between the Sys- 
tem A transporter and these cytoskeletal proteins. These 
data are the first to document an association of a Na+-de - 
pendent organic solute transporter with these membrane- 
cytoskeletal complexes. 
Fodrin/ankyrin binding to domain-specific integral 
membrane proteins may play a role in the maintenance of
the polarized state of epithelial cells [15,17,18,23]. In 
MDCK cells, fodrin/ankyrin complexes are preferentially 
associated with the basolateral membrane domain [17]. In 
contrast o these epithelial cells, the polarization of the 
hepatocyte is associated with maintenance of a canalicular 
specific domain that is involved in bile formation [40]. 
Performing immunohistochemistry on frozen liver thin sec- 
tions with the 2A12-1/1B1 antibody, we have confirmed 
previous reports that a-fodrin is present on each of the 
hepatocyte plasma membrane domains [41,42]. Basal Sys- 
tem A transport activity in liver is relatively low on both 
the basolateral nd canalicular domains, but the activity is 
increased up to 20-fold by a wide variety of stimuli [2,43]. 
Following glucagon treatment of rats, the initial increase in 
hepatic System A-mediated transport is detected on the 
basolateral surface of the hepatocyte, but with time the 
enhanced activity also appears on the canalicular mem- 
brane, transferred to the latter domain by transcytosis [7]. 
When the stimulation of transport has reached a maximum, 
the specific activity in the two membrane regions is nearly 
equal. Thus, detection of a-fodrin within both domains is 
consistent with this distribution of System A activity. 
Whether or not o~-fodrin plays a role in the sorting process 
prior to transcytosis or in the maintenance of hepatocyte 
polarity represents an interesting topic for future research. 
Furthermore, the role of these cytoskeletal proteins in the 
extensive regulation of System A transport remains to be 
investigated. 
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